The biotechnology services company disclosed robust annual performance driven by integrated offerings and international expansion execution.

Genscript Biotech Corp (GNNSF) reports a 61.4% revenue surge to $959.5 million, driven by strategic global expansion and key partnerships.

Genscript Biotech ( (HK:1548)) just unveiled an announcement. Genscript Biotech reported a sharp acceleration in operating performance for 2025, with revenue from continuing operations surging 61.4% ...

GenScript opens its first European mRNA production site in Delft, strengthens transatlantic biotechnology infrastructure: Delft, The Netherlands Saturday, March 14, 2026, 13:00 Hr ...

Strategic investment reinforces Europe as a core pillar of GenScript's global R&D and production network, following recent U.S. facility expansion.DELFT, Netherlands, March 12, 2026 /PRNewswire/ ...

Strategic investment reinforces Europe as a core pillar of GenScript's global R&D and production network, following recent ...

Detailed price information for Genscript Biotech Corp (GNNSF) from The Globe and Mail including charting and trades.

PISCATAWAY, N.J., Jan. 28, 2026 /PRNewswire/ -- GenScript Biotech Corporation, a global leader in life science research and biotech solutions, today announced its supporting role in the experimental ...

Good day and thank you for standing by. Welcome to Genscript Biotech 2025 Interim Results Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, ...

PISCATAWAY, N.J., Aug. 8, 2025 /PRNewswire/ -- GenScript Biotech Corporation (HK.1548), a global leader in life sciences innovation, today unveiled its new global brand platform: Scripting ...

PISCATAWAY, N.J., July 9, 2025 /PRNewswire/ -- GenScript Biotech Corporation (HK.1548), a leading global provider of life science research and manufacturing services, today announced that it has been ...